ARCHIVES

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

NCI “Leadership Vacuum” Deepened?

December 22, 1994

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

ACS Asks Congress For $1.32 Billion NCI ’87 Budget

April 4, 1986

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993

DCPC Advisors Okay New Program Project Grants In Prevention

January 27, 1995